- D.Phil. Biochemistry, University of Oxford
- B.Sc. Biochemistry, Imperial College London
- U.S. Patent and Trademark Office
Jean Xiaojin Xu, D.Phil.
Dr. Xu drafts patent applications, prosecutes U.S. patent applications (drafts responses, amendments, and appeal and reply briefs) and corresponds with foreign associates to guide the prosecution of foreign applications.Dr. Xu has over 10 years of research experience in a diverse range of technical areas, including molecular engineering, infectious diseases and immunology. Dr. Xu studied biochemistry as an undergraduate and her Ph.D. research focused on the structure-based design of antiviral drugs. Dr. Xu's post-doctoral research focused on the development of vaccines and the role of cellular metabolic pathways in providing long-term immunity. Dr. Xu has also served as a technology specialist in a small biotech company, supporting product development and commercialization.
Dr. Xu has co-authored many journal articles and textbooks, including "Autophagy is essential for effector CD8+ T cell survival and memory formation" (Nature Immunology, 2014); "mTOR, linking metabolism and immunity" (Seminars in Immunology, 2012); "Structural analysis of 1918 'Spanish' flu H1N1 neuraminidase" (Journal of Virology, 2008); "Structural determination of the 1918 H1N1 neuraminidase from a crystal with lattice-translocation defects" (Acta Crystallographica Section D: Biological Crystallography, 2008); "Transcriptome analysis of Anopheles stephensi - Plasmodium berghei interactions" (Molecular Biochemistry and Parasitology, 2005) and "SOAP, a novel malaria ookinete protein involved in mosquito midgut invasion and oocyst development" (Molecular Microbiology, 2003).
Dr. Xu is proficient in Mandarin Chinese.